Guangzhou Boji Medical & Biotechnological Co Ltd operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guangzhou Boji Medical & Biotechnological Co Ltd with three other
pharmaceutical manufacturers in Asia:
Ina Research Incorporation
sales of 2.43 billion Japanese Yen [US$22.27 million]
Genetics Generation Advancement Corp
(381.66 million Taiwanese Dollars [US$12.55 million]
Biotoxtech Company Limited
based in South Korea
(32.58 billion Korean Won [US$28.05 million]
During the year ended December of 2018, sales at
Guangzhou Boji Medical & Biotechnological Co Ltd were 172.04 million Chinese Renmimbi (US$24.58 million).
increase of 31.6%
versus 2017, when the company's sales were 130.75 million Chinese Renmimbi.